Investing.com -- Cognition Therapeutics Inc (NASDAQ: CGTX) stock surged 14% following the announcement of upcoming presentations of Phase 2 study results for its dementia with Lewy bodies (DLB) ...

Gabapentin, a common painkiller, may increase dementia risk with frequent use. Younger users are especially vulnerable.